Jason Agulnik

Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting

C. Chouaïd, Jason Agulnik, Erdem Göker et al. · Journal of Thoracic Oncology · 2013 · 144 citations · Full text

Pharmacy, Oncology, Health Assessment +16

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14

High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial

L. John Hoffer, Line Robitaille, Robert Zakarian et al. · PLoS ONE · 2015 · 118 citations · Full text

Medicine, Oncology, Pharmacology +15

High Risk of Deep Vein Thrombosis in Patients with Non-small Cell Lung Cancer: A Cohort Study of 493 Patients

Vicky Tagalakis, Dahlia Levi, Jason Agulnik et al. · Journal of Thoracic Oncology · 2007 · 117 citations · Full text

Medicine, Oncology, Surgery +15

Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer

H. Wang, Jason Agulnik, Goulnar Kasymjanova et al. · Annals of Oncology · 2018 · 111 citations · Full text

Medicine, Oncology, Pathology +17